RESUMEN

The study investigated spermicidal and antitrichomonas activities of selective serotonin reuptake inhibitor (SSRI) antidepressants with a view to generate new lead for development of dual-function spermicidal microbicides, which is an urgent global need. Fluoxetine, Sertraline, and Fluvoxamine exhibited both spermicidal and anti-STI (antitrichomonas) activities in vitro, whereas Paroxetine and Citalopram showed only the spermicidal activity. Fluoxetine exhibited better activity profile than the other antidepressant drugs with its spermicidal and antitrichomonas activities being comparable to that of the OTC contraceptive Nonoxynol-9. The non-detergent nature of Fluoxetine and a much lower spermicidal ED50 value (than N-9) may add considerably to its merit as a candidate for microbicidal contraceptive. Thus, the antidepressants exhibiting both spermicidal and antitrichomonas activities might provide useful lead for the development of novel, dual-function spermicidal contraceptives.

Asunto(s)

Antidepresivos/farmacología , Antitricomonas/farmacología , Inhibidores Selectivos de la Recaptación de Serotonina/farmacología , Espermicidas/farmacología , Espermatozoides/efectos de los fármacos , Trichomonas vaginalis/efectos de los fármacos , Animales , Antidepresivos/química , Antitricomonas/química , Evaluación Preclínica de Medicamentos , Fluoxetina/química , Fluoxetina/farmacología , Fluvoxamina/química , Fluvoxamina/farmacología , Humanos , Técnicas In Vitro , Masculino , Estructura Molecular , Inhibidores Selectivos de la Recaptación de Serotonina/química , Sertralina/química , Sertralina/farmacología , Espermicidas/química , Relación Estructura-Actividad